Big Pharma’s Johnson & Johnson Under Investigation in South Africa over ‘Excessive’ Drug Prices
By Gerald Imray
U.S.-based pharmaceuticals company Johnson & Johnson is being investigated in South Africa for allegedly charging “excessive” prices for a key tuberculosis drug, the country’s antitrust regulator said Friday.
J&J’s Belgium-based subsidiary Janssen Pharmaceuticals is also under investigation, South Africa’s Competition Commission said.
The commission, which regulates business practices, said it opened the investigation this week based on information that the companies “may have engaged in exclusionary practices and excessive pricing” of the tuberculosis drug bedaquiline, which is sold under the brand name Sirturo.
Source: The Associated Press (link opens in a new window)
- Categories
- Health Care
- Tags
- distribution
